Thalcin Profile Banner
Thierry Alcindor, MD, MSc Profile
Thierry Alcindor, MD, MSc

@Thalcin

Followers
950
Following
1K
Statuses
803

Oncologue médical/Hématologue, sarcomes et tumeurs digestives|Medical oncologist/Hematologist, sarcomas and GI |@danafarbernews and @harvardmed

Boston, MA
Joined December 2017
Don't wanna be here? Send us removal request.
@Thalcin
Thierry Alcindor, MD, MSc
@Thalcin
6 days
Nice work, @CostaPhilippos !
@JournalCancer
ACS Journal Cancer
@JournalCancer
6 days
Original work by @CostaPhilippos et al examines sorafenib- and anthracycline-based therapies for patients with #DesmoidTumors. Read the study: And an accompanying editorial from Dr. Bernd Kasper: @OncoAlert
Tweet media one
0
0
1
@Thalcin
Thierry Alcindor, MD, MSc
@Thalcin
8 days
That needs so much to be emphasized!
@DTRFoundation
Desmoid Tumor Research Foundation
@DTRFoundation
8 days
📣 #Desmoid tumors are non-metastasizing, and they are NOT benign. They're classified by the World Health Organization (WHO) as “intermediate (locally aggressive)” soft tissue tumors. Learn more: #SpreadTheWord #DTRF #Desmoidtumors
Tweet media one
Tweet media two
0
2
7
@Thalcin
Thierry Alcindor, MD, MSc
@Thalcin
12 days
@Thalcin
Thierry Alcindor, MD, MSc
@Thalcin
12 days
I was lucky, shortly after my arrival @DanaFarberNews , to be involved in that project led by @theaglab @BostonChildrens and @harvardmed , exploring the role of METTL1 gene in sarcomagenesis. From bench to the bedside, hopefully!
0
0
1
@Thalcin
Thierry Alcindor, MD, MSc
@Thalcin
12 days
I was lucky, shortly after my arrival @DanaFarberNews , to be involved in that project led by @theaglab @BostonChildrens and @harvardmed , exploring the role of METTL1 gene in sarcomagenesis. From bench to the bedside, hopefully!
0
0
5
@Thalcin
Thierry Alcindor, MD, MSc
@Thalcin
13 days
All acknoledgements matter, including a thank-you letter from an organization like ⁦@ASCO⁩ !
Tweet media one
0
0
13
@Thalcin
Thierry Alcindor, MD, MSc
@Thalcin
19 days
RT @Dr_ElvinaA: GISTs with this mutation show lower 18F-FDG uptake compared to other molecular subtypes, especially KIT exon 11–mutant GIST…
0
4
0
@Thalcin
Thierry Alcindor, MD, MSc
@Thalcin
20 days
A definitive answer in my opinion: FLOT periop chemo is better than preop CRT. Of ourse, when the study was designed, postop nivo after CRT was not standard of care and has not been shown yet to improve OS.
0
0
0
@Thalcin
Thierry Alcindor, MD, MSc
@Thalcin
21 days
RT @ryanhuey: Dr. Yoon discusses pathologic response in GEAC: not a great surrogate for survival. Great slide. #GI25
Tweet media one
0
20
0
@Thalcin
Thierry Alcindor, MD, MSc
@Thalcin
2 months
Enjoying the cultural offerings of ⁦@Harvard⁩ in Cambridge: this show combines Cape Verdian and Irish music!
Tweet media one
Tweet media two
0
1
6
@Thalcin
Thierry Alcindor, MD, MSc
@Thalcin
2 months
📢 Durvalumab and tremelimumab in patients with advanced rare cancer: a m... For UPS, hints of activity seen, below the required threshold stipulated by the protocol. No activity for osteosarcoma. Great effort by @CDNCancerTrials
0
3
5
@Thalcin
Thierry Alcindor, MD, MSc
@Thalcin
3 months
@realbowtiedoc @Annals_Oncology @OncoAlert @LizzySmyth1 @yekeduz_emre A well-done trial with clear results: Immunotherapy alone is not a good adjuvant regimen. Waiting now for the read-out of the trials combining chemotherapy and immunotherapy in the peri-operative setting.
0
0
0
@Thalcin
Thierry Alcindor, MD, MSc
@Thalcin
3 months
RT @JAMAOnc: A multi-institutional cohort study found that breast cancer patients with TP53 pathogenic variants who underwent radiation the…
0
48
0
@Thalcin
Thierry Alcindor, MD, MSc
@Thalcin
3 months
RT @srothschild: Couldn't make it to #CTOS2024? Come join @Thalcin for a webinar on CTOS Updates in #GIST
0
4
0
@Thalcin
Thierry Alcindor, MD, MSc
@Thalcin
3 months
@herbloong @ctosociety @Liferaftgroup Thanks for the shoutout!
0
0
3
@Thalcin
Thierry Alcindor, MD, MSc
@Thalcin
3 months
@stern_sydney Thank you for giving a voice to the patients.
0
1
4
@Thalcin
Thierry Alcindor, MD, MSc
@Thalcin
3 months
Thank you! It was a pleasure to be there.
@TGCTSupportorg
TGCT Support
@TGCTSupportorg
3 months
We caught up with some of our medical advisory board to discuss accomplishments of 2024 and set our sights on new goals for 2025. We can’t wait to see what’s next! 👏🏻👏🏻 thank you to all who could attend. #CTOS2024 @seppobauer
Tweet media one
Tweet media two
Tweet media three
0
0
10
@Thalcin
Thierry Alcindor, MD, MSc
@Thalcin
3 months
A positive signal in DDLPS with CK4 inhibition + PD-1 inhibition. Hoping that the Alliance trial (palbociclib vs. palbociclib + celiplimab) will validate that concept.
Tweet media one
0
0
4
@Thalcin
Thierry Alcindor, MD, MSc
@Thalcin
3 months
@CostaPhilippos I agree. And there is an unmet need for WDLPS.
0
0
1
@Thalcin
Thierry Alcindor, MD, MSc
@Thalcin
3 months
RT @wagsmd: ⁦@candace_haddox⁩ presenting SARC044 for patients with #GIST. Trial now open ⁦@DanaFarber⁩ #ctos
Tweet media one
0
14
0